Global Cell Culture Media Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2024 –2031 |
 시장 규모(기준 연도) |
USD 6.23 Billion |
 시장 규모(예측 연도) |
USD 14.87 Billion |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
>글로벌 세포 배양 배지 시장, 유형별(용원성 배지, 화학적으로 정의된 배지, 고전적 배지, 무혈청 배지, 특수 배지, 줄기세포 배지 및 기타 배지), 응용 분야(암 연구, 생물 약제, 재생 의학 및 조직 공학, 줄기세포 기술, 약물 발견 및 기타 응용 분야), 최종 사용자( 생명 공학 및 제약 산업, 학술 기관, 연구실 및 기타), 시약 유형(알부민, 아미노산, 부착 인자, 성장 인자 및 사이토카인, 호르몬 및 기타) - 산업 동향 및 2031년까지의 예측.
세포 배양 배지 시장 분석 및 규모
글로벌 세포 배양 배지 시장은 만성 질환의 유병률 증가, 생물 의약품 에 대한 수요 증가 , 생명 과학 연구에 대한 투자 증가와 같은 요인에 의해 꾸준한 성장을 경험하고 있습니다. 이 시장은 혈청 함유, 혈청 무함유 및 특수 배지를 포함한 광범위한 배지 유형이 특징으로, 다양한 세포 배양 요구에 부응합니다. 이 시장은 또한 윤리적 우려와 더 재현 가능한 결과에 대한 필요성에 의해 동물이 없고 화학적으로 정의된 배지로 전환되고 있습니다. 전반적으로 세포 배양 배지 시장은 생물 의약품에 대한 수요 증가와 생명 공학 및 제약 산업의 확장에 의해 더욱 성장할 준비가 되어 있습니다.
글로벌 세포 배양 배지 시장 규모는 2023년에 59억 2천만 달러로 평가되었으며, 2031년까지 110억 4천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 8.1%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.
보고 범위 및 시장 세분화
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2024년부터 2031년까지 |
|
기준 연도 |
2023 |
|
역사적 연도 |
2022 (2016~2021년까지 맞춤 설정 가능) |
|
양적 단위 |
매출은 10억 달러, 볼륨은 단위, 가격은 10억 달러 |
|
다루는 세그먼트 |
유형(용원성 배지, 화학적으로 정의된 배지, 고전적 배지, 혈청 없는 배지, 특수 배지, 줄기 세포 배지 및 기타 배지), 응용 분야(암 연구, 생물 약학, 재생 의학 및 조직 공학, 줄기 세포 기술, 약물 발견 및 기타 응용 분야), 최종 사용자(생명 공학 및 제약 산업, 학술 기관, 연구 실험실 및 기타), 시약 유형(알부민, 아미노산, 부착 인자, 성장 인자 및 사이토카인, 호르몬 및 기타) |
|
적용 국가 |
미국, 캐나다, 멕시코, 독일, 프랑스, 영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽 기타 지역, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양 기타 지역, 사우디 아라비아, UAE, 남아프리카, 이집트, 이스라엘, 중동 및 아프리카 기타 지역, 브라질, 아르헨티나, 남미 기타 지역 |
|
시장 참여자 포함 |
BD(미국), Life TechnologiesTM(미국), Thermo Fisher Scientific Inc.(미국), Corning Incorporated(미국), Sigma-Aldrich Co.(미국), Merck KGaA(독일), GENERAL ELECTRIC COMPANY(미국), Lonza(스위스), HiMedia Laboratories.(미국), Takara Bio Inc.(일본), AllCells(미국), PromoCell GmbH(독일), VWR International, LLC.(미국), Avantor, Inc.(미국), Bio-Rad Laboratories, Inc.(미국), Cell Culture Technologies.(스위스), FUJIFILM Holdings Corporation(일본), Sartorius AG(독일), Vitro Biopharma(미국), Eppendorf AG(독일) |
|
시장 기회 |
|
시장 정의
세포 배양 배지는 세포의 성장, 증식 및 유지를 시험관 내(실험실과 같은 자연 환경 외부)에서 지원하는 데 사용되는 영양이 풍부한 용액입니다. 이러한 배지는 아미노산 , 비타민 , 염, 당 및 성장 인자를 포함한 다양한 성분으로 구성되어 세포에 필요한 영양소와 성장 환경을 제공합니다.
세포 배양 배지 시장 동향
운전자
- 성장하는 생명공학 및 제약 산업
생명공학 및 제약 산업은 인구 고령화, 만성 질환 유병률 증가, 혁신적 치료법에 대한 필요성을 포함한 여러 요인에 의해 촉진되어 전 세계적으로 상당한 확장을 경험하고 있습니다. 세포 배양은 약물 발견, 개발 및 생산에 매우 중요하여 이러한 산업의 필수 구성 요소가 되었습니다. 회사가 새로운 치료법과 생물 의약품을 개발하기 위해 노력함에 따라 고급 세포 배양 기술과 제품에 대한 수요가 계속 증가하여 시장 성장을 촉진하고 있습니다.
- 재생 의학 연구 증가
재생 의학은 신체의 자연적 치유 및 조직 재생 능력을 활용하여 다양한 질병과 부상을 치료하는 데 유망합니다. 세포 배양은 이 연구에 필수적이며, 과학자들이 통제된 환경에서 줄기 세포를 성장시키고 조작할 수 있도록 합니다. 재생 의학 응용 분야에 맞게 맞춤 제작된 특수 세포 배양 배지, 스캐폴드 및 기타 제품에 대한 수요가 증가하고 있어 시장 성장의 기회가 제공됩니다. 이 분야의 연구가 진행됨에 따라 혁신적인 세포 배양 솔루션에 대한 필요성이 계속 증가하여 시장 확장을 촉진할 것입니다.
기회
- 줄기세포 연구 확대
Stem cells can uniquely differentiate into various cell types, making them valuable tools for studying development, disease modeling, and regenerative therapies. However, working with stem cells requires specialized culture techniques and products to maintain their pluripotency and viability. This expanding field presents opportunities for companies to develop advanced culture systems tailored for stem cell research, catering to the specific needs of researchers and advancing the capabilities of the market.
- Development of 3D Cell Culture Techniques
3D cell cultures enable cells to grow in a three-dimensional environment, resembling the intricate structure of tissues and organs in the body. his more realistic environment gives researchers a better understanding of cell behavior and interactions, leading to a more accurate representation of in vivo conditions. The development of 3D cell culture techniques has opened up new avenues for cell culture, creating new opportunities in the market.
Restraints/Challenges
- Contamination Risks in Cell Culture
Contamination can arise from a variety of sources, such as airborne particles, microbial contaminants, and cross-contamination from neighboring cell cultures.Contaminated cell cultures can result in misleading experimental results, wasted resources, and delays in research progress. Contamination of cell cultures can lead to the loss of valuable samples and compromised research outcomes, challenging the market growth.
- Ethical Concerns
Many cell culture media and supplements contain components derived from animals, raising ethical concerns regarding animal welfare and sustainability. In addition, using embryonic stem cells raises ethical questions regarding the source of the cells and the implications for human life. Ethical concerns surrounding cell culture practices can impact market growth, particularly regarding animal-derived products and embryonic stem cells, and can be a challenge for market growth.
This cell culture media market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cell culture media market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In July 2022, the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, initiated an early-stage clinical trial to assess an investigational vaccine designed to prevent Nipah virus infection. This experimental vaccine, developed in collaboration with NIAID's Vaccine Research Center, is manufactured by Moderna, Inc., headquartered in Cambridge, Massachusetts
- In October 2023, the London-based startup Multus Biotechnology focused on reducing the cost of cell culture media for cultivated meat by utilizing AI to optimize formulation efficiency. The startup addresses challenges related to ingredient quality, scalability, and bioprocess productivity, to improve the sustainability and cost-effectiveness of cell culture media
- In July 2023, MilliporeSigma announced a USD 25 million investment to expand its cell culture media production facility in Lenexa, Kansas. The expansion included 98,000 ft2 of lab space, demonstrating the company's commitment to meeting the growing demand for cell culture media. Lenexa now serves as one of the three global centers of excellence for dry powder cell culture media manufacturing
Cell Culture Media Market Scope
The cell culture media market is segmented on the basis of type, application, end user, and reagent type. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Lysogenic Broth
- Chemically Defined Media
- Classical Media
- Serum-Free Media
- Specialty Media
- Stem Cell Media
- Other Media
Application
- Cancer Research
- Biopharmaceuticals
- Regenerative Medicine and Tissue Engineering
- Stem Cell Technology
- Drug Discovery
- Other Applications
End User
- Biotechnology and Pharmaceutical Industry
- Academic Institute
- Research Laboratory
- Others
Reagent Type
- Albumin
- Amino Acids
- Attachment Factors
- Growth Factors and Cytokines
- Hormones
- Others
Cell Culture Media Market Regional Analysis/Insights
The cell culture media market is analyzed and market size insights and trends are provided by country, type, application, end user, and reagent type as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
North America is expected to dominate the market due to the pharmaceutical and biotechnology industries in the region undergoing significant growth, which leads to a rise in the demand for cell culture products. Furthermore, the region has a substantial investment in research and development (R&D), especially in advanced biotechnology research.
아시아 태평양 지역은 연구 및 생명공학 응용 분야에서 세포 배양 기술을 사용하는 것과 관련된 인식이 증가함에 따라 예측 기간 동안 상당한 성장을 목격할 것으로 예상됩니다. 세포 배양 기술에 대한 인식이 증가함에 따라 아시아 태평양 국가들은 의료 인프라와 연구 역량에 점점 더 많은 투자를 하고 있습니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
의료 인프라 성장 설치 기반 및 신기술 침투
세포 배양 배지 시장은 또한 자본 장비에 대한 의료 지출의 모든 국가별 성장, 세포 배양 배지 시장을 위한 다양한 종류의 제품의 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 세포 배양 배지 시장에 미치는 영향에 대한 자세한 시장 분석을 제공합니다. 이 데이터는 2011-2021년의 과거 기간에 대해 제공됩니다.
경쟁 환경 및 세포 배양 배지 시장 점유율 분석
세포 배양 배지 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.
시장에서 활동하는 주요 기업은 다음과 같습니다.
- BD(미국)
- Life TechnologiesTM (미국)
- Thermo Fisher Scientific Inc. (미국)
- 코닝 주식회사(미국)
- 시그마-알드리치(Sigma-Aldrich Co.)(미국)
- 머크 KGaA(독일)
- 제너럴 일렉트릭 컴퍼니(미국)
- 론자(스위스)
- HiMedia 연구소(미국)
- 다카라바이오 주식회사(일본)
- 올셀스(미국)
- PromoCell GmbH(독일)
- VWR 인터내셔널, LLC.(미국)
- Avantor, Inc.(미국)
- Bio-Rad Laboratories, Inc.(미국)
- 세포 배양 기술. (스위스)
- 후지필름 홀딩스 주식회사(일본)
- Sartorius AG(독일)
- 비트로 바이오파마(미국)
- 에펜도르프 AG(독일)
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL CELL CULTURE MEDIA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 GLOBAL CELL CULTURE MEDIA MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE
6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE
6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS
6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT
6.2 RESTRAINTS
6.2.1 RISKS ASSOCIATED WITH CONTAMINATION
6.2.2 HIGH COST OF PRODUCTION
6.3 OPPORTUNITIES
6.3.1 RISING COLLABORATION AND PARTNERSHIPS
6.3.2 INCREASED DEMAND FOR BIOPHARMACEUTICALS AND VACCINES
6.3.3 INNOVATIONS IN 3D CELL CULTURE
6.4 CHALLENGES
6.4.1 COMPLEXITY OF MEDIA FORMULATION
6.4.2 INTENSE MARKET COMPETITION
7 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE
7.1 OVERVIEW
7.2 CHEMICALLY DEFINED MEDIA
7.3 CLASSICAL MEDIA
7.4 SERUM-FREE MEDIA
7.4.1 CHO MEDIA
7.4.2 HEK 293 MEDIA
7.4.3 CAR T-CELL MEDIA
7.4.4 VERO CELL MEDIA
7.4.5 BHK MEDIA
7.4.6 INSECT CELL MEDIA
7.4.7 SERUM-FREE CELL MEDIA
7.4.8 OTHER SERUM-FREE MEDIA
7.5 SPECIALTY MEDIA
7.6 STEM CELL MEDIA
7.6.1 MESENCHYMAL STEM CELLS (MSCS)
7.6.2 NEURAL STEM CELLS (NSCS)
7.6.3 EMBRYONIC STEM CELLS (ESCS)
7.6.4 BONE MARROW
7.6.5 OTHERS
7.7 LYSOGENY BROTH (LB)
7.8 CUSTOM MEDIA FORMULATION
7.9 OTHERS
8 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 BIOPHARMACEUTICAL PRODUCTION
8.2.1 MONOCLONAL ANTIBODIES
8.2.2 VACCINES PRODUCTION
8.2.3 OTHERS
8.3 DRUG SCREENING & DEVELOPMENT
8.4 DIAGNOSTICS
8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING
8.5.1 STEM CELL AND GENE THERAPY
8.5.2 OTHERS
8.6 OTHERS
9 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER
9.1 OVERVIEW
9.2 BIOPHARMACEUTICAL COMPANIES
9.3 BIOTECHNOLOGY ORGANIZATIONS
9.4 ACADEMIC AND RESEARCH LABORATORIES
9.5 HOSPITALS
9.6 DIAGNOSTIC CENTERS
9.7 CELL BANKS
9.8 FORENSIC LABORATORIES
9.9 OTHERS
10 GLOBAL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDERS
10.3 THIRD PARTY DISTRIBUTION
10.4 RETAILS SALES
11 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 GERMANY
11.3.2 U.K.
11.3.3 FRANCE
11.3.4 NETHERLANDS
11.3.5 SPAIN
11.3.6 SWITZERLAND
11.3.7 BELGIUM
11.3.8 ITALY
11.3.9 RUSSIA
11.3.10 TURKEY
11.3.11 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 JAPAN
11.4.3 INDIA
11.4.4 SOUTH KOREA
11.4.5 AUSTRALIA
11.4.6 SINGAPORE
11.4.7 THAILAND
11.4.8 MALAYSIA
11.4.9 INDONESIA
11.4.10 PHILIPPINES
11.4.11 REST OF ASIA-PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.2 ARGENTINA
11.5.3 REST OF SOUTH AMERICA
11.6 MIDDLE EAST AND AFRICA
11.6.1 SOUTH AFRICA
11.6.2 SAUDI ARABIA
11.6.3 U.A.E
11.6.4 EGYPT
11.6.5 ISRAEL
11.6.6 REST OF MIDDLE EAST AND AFRICA
12 GLOBAL MULTIPLE HEREDITARY EXOSTOSIS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.2 MERCK KGAA
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 DANAHER CORPORATION (CYTIVA)
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 SARTORIUS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 LONZA
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENT
14.6 CORNING INCORPORATED
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 COMPANY SHARE ANALYSIS
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT UPDATES
14.7 AJINOMOTO CO., INC
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 AKRON BIOTECH
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 BD
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT UPDATES
14.1 BIO-RAD LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENT
14.11 CAISSON LABS INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT UPDATES
14.12 CELL APPLICATION, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT UPDATES
14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 FUJIFILM HOLDINGS CORPORATION
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT UPDATES
14.15 HIMEDIA LABORATORIES
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT UPDATES
14.16 KOH JIN-BIO CO., LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT UPDATES
14.17 PAN-BIOTECH
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT UPDATES
14.18 PROMOCELL GMBH
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT UPDATES
14.19 SERA-SCANDIA A/S
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 STEMCELL TECHNOLOGIES
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 TAKARA BIO INC.
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
표 목록
TABLE 1 GMP REQUIREMENTS
TABLE 2 SCOPE OF THE CURRENT DOCUMENT
TABLE 3 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 4 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 5 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 6 GLOBAL CHEMICALLY DEFINED MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 GLOBAL CLASSICAL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 8 GLOBAL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 9 GLOBAL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 10 GLOBAL SPECIALTY MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 11 GLOBAL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 GLOBAL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 13 GLOBAL LYSOGENY BROTH (LB) IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 14 GLOBAL CUSTOM MEDIA FORMULATION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 15 GLOBAL OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 16 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 17 GLOBAL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 18 GLOBAL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 19 GLOBAL DRUG SCREENING & DEVELOPMENT IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 GLOBAL DIAGNOSTICS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 21 GLOBAL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 GLOBAL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 GLOBAL OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 24 GLOBAL CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 25 GLOBAL BIOPHARMACEUTICAL COMPANIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 26 GLOBAL BIOTECHNOLOGY ORGANIZATIONS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 GLOBAL ACADEMIC AND RESEARCH LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 28 GLOBAL HOSPITALS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 29 GLOBAL DIAGNOSTIC CENTERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 30 GLOBAL CELL BANKS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 31 GLOBAL FORENSIC LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 GLOBAL OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 33 GLOBAL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 34 GLOBAL DIRECT TENDERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 35 GLOBAL THIRD PARTY DISTRIBUTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 36 GLOBAL RETAIL SALES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 37 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 38 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 39 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 40 NORTH AMERICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 41 NORTH AMERICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 42 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 43 NORTH AMERICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 44 NORTH AMERICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 45 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 46 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 47 U.S. CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 48 U.S. SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 49 U.S. STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 50 U.S. CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 51 U.S. BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 U.S. REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 53 U.S. CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 54 U.S. CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 55 CANADA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 56 CANADA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 57 CANADA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 58 CANADA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 59 CANADA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 60 CANADA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 61 CANADA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 62 CANADA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 63 MEXICO CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 64 MEXICO SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 MEXICO STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 66 MEXICO CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 67 MEXICO BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 68 MEXICO REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 69 MEXICO CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 70 MEXICO CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 71 EUROPE CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 72 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 73 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 74 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 75 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 76 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 77 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 78 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 79 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 80 GERMANY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 81 GERMANY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 82 GERMANY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 83 GERMANY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 84 GERMANY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 85 GERMANY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 86 GERMANY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 87 GERMANY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 88 U.K. CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 U.K. SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 90 U.K. STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 91 U.K. CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 92 U.K. BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 93 U.K. REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 94 U.K. CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 95 U.K. CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 96 FRANCE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 97 FRANCE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 98 FRANCE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 99 FRANCE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 100 FRANCE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 101 FRANCE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 102 FRANCE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 103 FRANCE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 104 NETHERLANDS CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 105 NETHERLANDS SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 106 NETHERLANDS STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 107 NETHERLANDS CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 108 NETHERLANDS BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 NETHERLANDS REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 110 NETHERLANDS CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 111 NETHERLANDS CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 112 SPAIN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 113 SPAIN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 114 SPAIN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 115 SPAIN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 116 SPAIN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 117 SPAIN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 118 SPAIN CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 119 SPAIN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 120 SWITZERLAND CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 121 SWITZERLAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 122 SWITZERLAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 123 SWITZERLAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 124 SWITZERLAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 125 SWITZERLAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 126 SWITZERLAND CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 127 SWITZERLAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 128 BELGIUM CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 129 BELGIUM SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 130 BELGIUM STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 BELGIUM CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 132 BELGIUM BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 133 BELGIUM REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 134 BELGIUM CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 135 BELGIUM CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 136 ITALY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 137 ITALY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 138 ITALY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 139 ITALY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 140 ITALY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 141 ITALY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 142 ITALY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 143 ITALY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 144 RUSSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 145 RUSSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 146 RUSSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 147 RUSSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 148 RUSSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 149 RUSSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 150 RUSSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 151 RUSSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 152 TURKEY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 153 TURKEY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 154 TURKEY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 155 TURKEY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 156 TURKEY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 157 TURKEY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 158 TURKEY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 159 TURKEY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 160 REST OF EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 161 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 162 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 163 ASIA-PACIFIC SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 164 ASIA-PACIFIC STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 165 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 166 ASIA-PACIFIC BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 167 ASIA-PACIFIC REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 168 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 169 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 170 CHINA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 171 CHINA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 172 CHINA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 173 CHINA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 174 CHINA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 175 CHINA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 176 CHINA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 177 CHINA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 178 JAPAN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 179 JAPAN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 180 JAPAN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 181 JAPAN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 182 JAPAN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 183 JAPAN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 184 JAPAN CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 185 JAPAN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 186 INDIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 187 INDIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 188 INDIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 189 INDIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 190 INDIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 191 INDIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 192 INDIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 193 INDIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 194 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 195 SOUTH KOREA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 196 SOUTH KOREA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 197 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 198 SOUTH KOREA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 199 SOUTH KOREA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 200 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 201 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 202 AUSTRALIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 203 AUSTRALIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 204 AUSTRALIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 205 AUSTRALIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 206 AUSTRALIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 207 AUSTRALIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 208 AUSTRALIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 209 AUSTRALIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 210 SINGAPORE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 211 SINGAPORE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 212 SINGAPORE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 213 SINGAPORE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 214 SINGAPORE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 215 SINGAPORE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 216 SINGAPORE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 217 SINGAPORE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 218 THAILAND CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 219 THAILAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 220 THAILAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 221 THAILAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 222 THAILAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 223 THAILAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 224 THAILAND CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 225 THAILAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 226 MALAYSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 227 MALAYSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 228 MALAYSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 229 MALAYSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 230 MALAYSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 231 MALAYSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 232 MALAYSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 233 MALAYSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 234 INDONESIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 235 INDONESIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 236 INDONESIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 237 INDONESIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 238 INDONESIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 239 INDONESIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 240 INDONESIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 241 INDONESIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 242 PHILIPPINES CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 243 PHILIPPINES SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 244 PHILIPPINES STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 245 PHILIPPINES CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 246 PHILIPPINES BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 247 PHILIPPINES REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 248 PHILIPPINES CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 249 PHILIPPINES CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 250 REST OF ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 251 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 252 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 253 SOUTH AMERICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 254 SOUTH AMERICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 255 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 256 SOUTH AMERICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 257 SOUTH AMERICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 258 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 259 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 260 BRAZIL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 261 BRAZIL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 262 BRAZIL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 263 BRAZIL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 264 BRAZIL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 265 BRAZIL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 266 BRAZIL CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 267 BRAZIL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 268 ARGENTINA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 269 ARGENTINA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 270 ARGENTINA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 271 ARGENTINA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 272 ARGENTINA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 273 ARGENTINA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 274 ARGENTINA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 275 ARGENTINA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 276 REST OF SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 277 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 278 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 279 MIDDLE EAST AND AFRICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 280 MIDDLE EAST AND AFRICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 281 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 282 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 283 MIDDLE EAST AND AFRICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 284 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 285 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 286 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 287 SOUTH AFRICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 288 SOUTH AFRICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 289 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 290 SOUTH AFRICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 291 SOUTH AFRICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 292 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 293 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 294 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 295 SAUDI ARABIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 296 SAUDI ARABIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 297 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 298 SAUDI ARABIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 299 SAUDI ARABIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 300 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 301 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 302 U.A.E CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 303 U.A.E SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 304 U.A.E STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 305 U.A.E CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 306 U.A.E BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 307 U.A.E REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 308 U.A.E CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 309 U.A.E CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 310 EGYPT CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 311 EGYPT SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 312 EGYPT STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 313 EGYPT CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 314 EGYPT BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 315 EGYPT REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 316 EGYPT CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 317 EGYPT CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 318 ISRAEL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 319 ISRAEL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 320 ISRAEL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 321 ISRAEL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 322 ISRAEL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 323 ISRAEL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 324 ISRAEL CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 325 ISRAEL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 326 REST OF MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
그림 목록
FIGURE 1 GLOBAL CELL CULTURE MEDIA MARKET: SEGMENTATION
FIGURE 2 GLOBAL CELL CULTURE MEDIA MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL CELL CULTURE MEDIA MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL CELL CULTURE MEDIA MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL CELL CULTURE MEDIA MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL CELL CULTURE MEDIA MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL CELL CULTURE MEDIA MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL CELL CULTURE MEDIA MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL CELL CULTURE MEDIA MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL CELL CULTURE MEDIA MARKET: SEGMENTATION
FIGURE 11 EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE IS DRIVING THE GROWTH OF THE GLOBAL CELL CULTURE MEDIA MARKET FROM 2024 TO 2031
FIGURE 14 THE CHEMICALLY DEFINED MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CELL CULTURE MEDIA MARKET IN 2024 AND 2031
FIGURE 15 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL CELL CULTURE MEDIA MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 16 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR CELL CULTURE MEDIA MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 17 DROC ANALYSIS
FIGURE 18 GLOBAL CELL CULTURE MEDIA MARKET: BY TYPE, 2023
FIGURE 19 GLOBAL CELL CULTURE MEDIA MARKET: BY TYPE, 2024-2031 (USD MILLION)
FIGURE 20 GLOBAL CELL CULTURE MEDIA MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 21 GLOBAL CELL CULTURE MEDIA MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 GLOBAL CELL CULTURE MEDIA MARKET: BY APPLICATION, 2023
FIGURE 23 GLOBAL CELL CULTURE MEDIA MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 24 GLOBAL CELL CULTURE MEDIA MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 25 GLOBAL CELL CULTURE MEDIA MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 GLOBAL CELL CULTURE MEDIA MARKET: BY END USER, 2023
FIGURE 27 GLOBAL CELL CULTURE MEDIA MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 28 GLOBAL CELL CULTURE MEDIA MARKET: BY END USER, CAGR (2024-2031)
FIGURE 29 GLOBAL CELL CULTURE MEDIA MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 GLOBAL CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 31 GLOBAL CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 32 GLOBAL CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 33 GLOBAL CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 GLOBAL CELL CULTURE MEDIA MARKET: SNAPSHOT
FIGURE 35 GLOBAL CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
FIGURE 36 NORTH AMERICA CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
FIGURE 37 EUROPE CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
FIGURE 38 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
